AI POWER: Genomenon Unveils Groundbre... - Fight Prostate Ca...

Fight Prostate Cancer

3,036 members1,517 posts

AI POWER: Genomenon Unveils Groundbreaking Genomic Knowledgebase

Maxone73 profile image
3 Replies

Normally I prefer not to mention the company name but in this case...kudos!

Genomenon has developed the Genomenon Genomic Graph (G3) knowledgebase, a searchable database of all clinically relevant genomic evidence. This knowledgebase includes data from published scientific and medical studies and is powered by a genomic-specific large language model (LLM). The G3 knowledgebase contains information on genes, genetic variants, diseases, drugs, and patient demographics. It enables advanced literature searches with natural language queries and can generate actionable patient insights. The AI platform is designed to handle complex data, including historical trends and evolving nomenclatures. The knowledgebase is designed to improve biomedical research, drug development, and clinical diagnostics

prostatewarriors.com/2024/1...

Written by
Maxone73 profile image
Maxone73
To view profiles and participate in discussions please or .
3 Replies
KocoPr profile image
KocoPr

This is GREAT news! Now is it available for the patient? Can ChatGPT query it?

Maxone73 profile image
Maxone73 in reply toKocoPr

I have not uderstood yet. Thats a for profit company that sells their software services but I dont know if this part is publicly available

KocoPr profile image
KocoPr in reply toMaxone73

Well ChatGPT should do this also

Not what you're looking for?

You may also like...

Interesting if you are following AI evolution

Well, Google seems to have introduced what is considered the most advanced AI today (and it's open...
Maxone73 profile image

Repurposing advances

AI-driven drug repurposing platform offers new hope for cancer patients by reviving abandoned drugs...
Maxone73 profile image

First BAT cycle results: what next?

I started my first BAT cycle on 3-12-24, originally designed to last for 32 days. PSA was...

Great update: 67Cu-SAR-bisPSMA gets fast tracked by FDA

And it looks like it is way more reliable than 177Lu... The FDA has granted Fast Track Designation...
Maxone73 profile image

ASCO GU 2025: new data confirms triplet therapy benefits, especially with darolutamide

A new population-adjusted analysis confirms that the combination of darolutamide, ADT, and...
Maxone73 profile image

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.